Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?

Article navigation

Commentary| August 01 1995

P S Linsley

Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.

Search for other works by this author on:

PubMed

P S Linsley

Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.

Online ISSN: 1540-9538

Print ISSN: 0022-1007

J Exp Med (1995) 182 (2): 289–292.

https://doi.org/10.1084/jem.182.2.289

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Sign in